Polygala fallax Hemsl combined with compound Sanqi granules relieves glomerulonephritis by regulating proliferation and apoptosis of glomerular mesangial cells
机构:[1]Guangdong Yifang Pharmaceutical Co. Ltd., Foshan, China[2]Guilin Medical University, Guilin, China[3]Department of Nephrology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China[4]Wuqing Hospital of Traditional Chinese Medicine Affiliated to Tianjin University of Traditional Chinese Medicine, Tianjin, China[5]Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, Second Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China大德路总院肾内科大德路总院肾内科广东省中医院
Objectives: Glomerulonephritis is a serious kidney disease that can induce end-stage renal failure. The aberrant proliferation of mesangial cells is a cause of glomerulonephritis. Traditional Chinese medicines, such as Astragalus and Salvia miltrorrhiza, play important roles in the treatment of kidney-related diseases. However, the effects of a combination of Astragalus and S. miltrorrhiza-containing traditional Chinese medicines (Polygala fallax Hemsl and compound Sanqi granules) on glomerulonephritis are unclear. Methods: HRM cells (human mesangial cells) were stimulated with lipopolysaccharide to simulate glomerulonephritis. Separately, compound Sanqi granules and P. fallax Hemsl were administered to nude mice in various combinations. Serum was collected from the treated mice and added to HRM cells; the proliferation and apoptosis characteristics of the cells were assessed. Results: The proliferation of HRM cells was inhibited after exposure to serum from treated mice. Exposure to serum from treated mice moderately induced apoptosis of HRM cells and lowered the expression levels of TNF-alpha, IL-1 beta, and IL-6. Conclusions: Combination treatment with compound Sanqi granules and P. fallax Hemsl exerts a therapeutic effect on glomerulonephritis by inhibiting the proliferation of mesangial cells, while inducing apoptosis in those cells.
语种:
外文
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类|4 区医学
小类|4 区医学:研究与实验4 区药学
最新[2025]版:
大类|4 区医学
小类|4 区医学:研究与实验4 区药学
JCR分区:
出版当年[2018]版:
Q4PHARMACOLOGY & PHARMACYQ4MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q4MEDICINE, RESEARCH & EXPERIMENTALQ4PHARMACOLOGY & PHARMACY
第一作者机构:[1]Guangdong Yifang Pharmaceutical Co. Ltd., Foshan, China
共同第一作者:
通讯作者:
通讯机构:[5]Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, Second Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China[*1]Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, Second Affiliated Hospital, Guangzhou University of Chinese Medicine, No. 111, Dade Road, Guangzhou, Guangdong 510000, China
推荐引用方式(GB/T 7714):
Chao Shiwei,Xu Qin,Dong Shaoning,et al.Polygala fallax Hemsl combined with compound Sanqi granules relieves glomerulonephritis by regulating proliferation and apoptosis of glomerular mesangial cells[J].JOURNAL OF INTERNATIONAL MEDICAL RESEARCH.2020,48(1):doi:10.1177/0300060519894124.
APA:
Chao, Shiwei,Xu, Qin,Dong, Shaoning,Guo, Min,Liu, Xusheng&Cheng, Xueren.(2020).Polygala fallax Hemsl combined with compound Sanqi granules relieves glomerulonephritis by regulating proliferation and apoptosis of glomerular mesangial cells.JOURNAL OF INTERNATIONAL MEDICAL RESEARCH,48,(1)
MLA:
Chao, Shiwei,et al."Polygala fallax Hemsl combined with compound Sanqi granules relieves glomerulonephritis by regulating proliferation and apoptosis of glomerular mesangial cells".JOURNAL OF INTERNATIONAL MEDICAL RESEARCH 48..1(2020)